Chapter 5 Expression of Chemokines and Chemokine Receptors in Human Colon Cancer

Methods in Enzymology

Volumn 460, Issue A, 2009, Pages 105-121

  Erreni, Marco ^a   Bianchi, Paolo ^a   Laghi, Luigi ^a   Mirolo, Massimiliano ^b   Fabbri, Marco ^a   Locati, Massimo ^b   Mantovani, Alberto ^b   Allavena, Paola ^a  

^a Department of Medicine   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOTACTIC FACTOR; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MATRIX ATTACHMENT REGION BINDING PROTEIN; MESSENGER RNA; OSTEOPONTIN; RANTES; RNA;

ANGIOGENESIS; CANCER CELL CULTURE; CELL MIGRATION; CELL SURVIVAL; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MACROPHAGE; MEDIATOR; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVIEW; STATISTICAL ANALYSIS; T LYMPHOCYTE; UPREGULATION; ARTICLE; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CHEMOKINES; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OSTEOPONTIN; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 65549143703     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)05205-7     Document Type: Review

References (37)

1. Allavena P., Sica A., Garlanda C., and Mantovani A. The yin-yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol. Rev. 222 (2008) 155-161
2. Bailey C., Negus R., Morris A., Ziprin P., Goldin R., Allavena P., Peck D., and Darzi A. Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer. Clin. Exp. Metastasis 24 (2007) 121-130
3. Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 4 (2004) 540-550
4. Bellahcene A., Castronovo V., Ogbureke K.U., Fisher L.W., and Fedarko N.S. Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): Multifunctional proteins in cancer. Nat. Rev. Cancer 8 (2008) 212-226
5. Bertagnolli M.M. The potential of non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention. J. Surg. Oncol. 84 (2003) 113-119
6. Caruso D.J., Carmack A.J., Lokeshwar V.B., Duncan R.C., Soloway M.S., and Lokeshwar B.L. Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence. Clin. Cancer Res. 14 (2008) 4111-4118
7. Chlenski A., Liu S., Guerrero L.J., Yang Q., Tian Y., Salwen H.R., Zage P., and Cohn S.L. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix. Int. J. Cancer 118 (2006) 310-316
8. Clark C.J., and Sage E.H. A prototypic matricellular protein in the tumor microenvironment-where there's SPARC, there's fire. J. Cell Biochem. 104 (2008) 721-732
9. Coukos G., Conejo-Garcia J.R., Roden R.B., and Wu T.C. Immunotherapy for gynaecological malignancies. Expert Opin. Biol. Ther. 5 (2005) 1193-1210
10. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
11. Deconto R.M., Pollard D., Wilson P.A., Palike H., Lear C.H., and Pagani M. Thresholds for Cenozoic bipolar glaciation. Nature 455 (2008) 652-656
12. Dunn G.P., Old L.J., and Schreiber R.D. The three Es of cancer immunoediting. Annu. Rev. Immunol. 22 (2004) 329-360
13. Forssell J., Oberg A., Henriksson M.L., Stenling R., Jung A., and Palmqvist R. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin. Cancer Res. 13 (2007) 1472-1479
14. Galon J., Costes A., Sanchez-Cabo F., Kirilovsky A., Mlecnik B., Lagorce-Pages C., Tosolini M., Camus M., Berger A., Wind P., Zinzindohoue F., Bruneval P., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313 (2006) 1960-1964
15. Graudens E., Boulanger V., Mollard C., Mariage-Samson R., Barlet X., Gremy G., Couillault C., Lajemi M., Piatier-Tonneau D., Zaborski P., Eveno E., Auffray C., et al. Deciphering cellular states of innate tumor drug responses. Genome Biol. 7 (2006) R19
16. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006) 431-436
17. Karin M., and Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5 (2005) 749-759
18. Koh A., da Silva A.P., Bansal A.K., Bansal M., Sun C., Lee H., Glogauer M., Sodek J., and Zohar R. Role of osteopontin in neutrophil function. Immunology 122 (2007) 466-475
19. Lu B., Xu J., Chen J., Yu J., Xu E., and Lai M. TaqMan low density array is roughly right for gene expression quantification in colorectal cancer. Clin. Chim. Acta 389 (2008) 146-151
20. Mantovani A. Cancer: Inflammation by remote control. Nature 435 (2005) 752-753
21. Mantovani A., Allavena P., Sica A., and Balkwill F. Cancer-related inflammation. Nature 454 (2008) 436-444
22. Mantovani A., Muzio M., Garlanda C., Sozzani S., and Allavena P. Macrophage control of inflammation: Negative pathways of regulation of inflammatory cytokines. Novartis Found. Symp. 234 (2001) 120-131 discussion 131-135
23. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25 (2004) 677-686
24. Mantovani A., Sozzani S., Locati M., Allavena P., and Sica A. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23 (2002) 549-555
25. McAllister S.S., Gifford A.M., Greiner A.L., Kelleher S.P., Saelzler M.P., Ince T.A., Reinhardt F., Harris L.N., Hylander B.L., Repasky E.A., and Weinberg R.A. Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 133 (2008) 994-1005
26. Murphy P.M. Chemokines and the molecular basis of cancer metastasis. N. Engl. J. Med. 345 (2001) 833-835
27. Pages F., Berger A., Camus M., Sanchez-Cabo F., Costes A., Molidor R., Mlecnik B., Kirilovsky A., Nilsson M., Damotte D., Meatchi T., Bruneval P., et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med. 353 (2005) 2654-2666
28. Podhajcer O.L., Benedetti L., Girotti M.R., Prada F., Salvatierra E., and Llera A.S. The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host. Cancer Metastasis Rev. 27 (2008) 523-537
29. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4 (2004) 71-78
30. Richmond A. Nf-kappa B, chemokine gene transcription and tumour growth. Nat. Rev. Immunol. 2 (2002) 664-674
31. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18 (2000) 217-242
32. Sangaletti S., Di Carlo E., Gariboldi S., Miotti S., Cappetti B., Parenza M., Rumio C., Brekken R.A., Chiodoni C., and Colombo M.P. Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. Cancer Res. 68 (2008) 9050-9059
33. Schottelius A.J., and Dinter H. Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer. Cancer Treat. Res. 130 (2006) 67-87
34. Sica A., and Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117 (2007) 1155-1166
35. Strieter R.M., Burdick M.D., Mestas J., Gomperts B., Keane M.P., and Belperio J.A. Cancer CXC chemokine networks and tumour angiogenesis. Eur. J. Cancer 42 (2006) 768-778
36. Taylor R.C., Patel A., Panageas K.S., Busam K.J., and Brady M.S. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J. Clin. Oncol. 25 (2007) 869-875
37. Wai P.Y., and Kuo P.C. Osteopontin: Regulation in tumor metastasis. Cancer Metastasis Rev. 27 (2008) 103-118